Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eylea for persistent DME after bevacizumab and ranibizumab (ROTATED)
NCT03340610Phase 4Completed
- Sponsor
- Southeast Retina Center
- Start
- Jun 2015
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
A Phase 4 trial of aflibercept in diabetic macular edema (DME), sponsored by Southeast Retina Center. Started Jun 2015; status: completed.
02
Drugs
aflibercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT03340610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03340610.